Every trade that managers of Sicagen disclose to SEBI (PIT + SAST) is tracked on this page. In the past year (18 October 2025 to 18 October 2026), 4 filings came from 4 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
For context, the typical company on the same exchange (median of 1,985 companies) published 4 filings over the same period, against 4 filings here.
No insider has bought Sicagen shares on the open market in the past twelve months. The median gap between trade and publication is zero days: most filings appear on the same day. Until a filing is published, the market cannot know about the trade.
Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended March 2026 · cache
4 of 4 declarations
Sicagen is a company listed on the Bombay Stock Exchange, engaged in various sectors. It focuses on innovation and the development of technological solutions.